Stem Cell Assay Market By Type (Viability/Cytotoxicity, Isolation/Purification, Cell Identification, Proliferation, Cell Differentiation, Cell Function, and Cell Apoptosis Assays), By Kit (Adult Stem Cells Kit and Human Embryonic Stem Cells Kits), By Detection (Instruments and Detection Kits), By Instrument (Flow Cytometer, Micro Electrode Arrays, Cell Imaging Systems, and Automated Cell Counter), By Application (Regenerative Medicine And Therapy Development, Drug Discovery & Development, and Clinical Research), By End User, and By Region- Trends, Analysis and Forecast till 2034

Report Code: PMI391020 | Publish Date: April 2024 | No. of Pages: 180

Global Stem Cell Assay Market Companies

  • GE Healthcare
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Cell Biolabs, Inc.
  • Hemogenix
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • R&D Systems Inc
  • Cellular Dynamics International Inc.

Recent News:

  • In September 2022, Century Therapeutics and Bristol Myers Squibb announced a licensing agreement and research collaboration to develop and commercialize allogeneic iPSC-derived cell therapies.
  • In May 2020, the CiRA Foundation and CGT Catapult launched a new collaborative research project to characterize induced pluripotent stem cells. The companies will combine their skills to explore new approaches to characterize pluripotent stem cells for the manufacture of regenerative medicine products. 
  • Celavie Biosciences’ five-year discovery study of Parkinson’s disease was launched in May 2020. The company is investigating regenerative stem cell therapies to treat Parkinson’s disease and other central nervous system disorders. Celavie Biosciences announced that preliminary clinical trials using OK99 stem cells for Parkinson's disease were successful.